InvestorsObserver
×
News Home

Vivos Therapeutics Inc (VVOS) Down 33.73% in Premarket Trading

Thursday, November 30, 2023 06:40 AM | InvestorsObserver Analysts

Mentioned in this article

Vivos Therapeutics Inc (VVOS) Down 33.73% in Premarket Trading

Vivos Therapeutics Inc (VVOS) has fallen Thursday morning, with the stock declining -33.73% in pre-market trading to 27.17. VVOS's short-term technical score of 100 indicates that the stock has traded more bullishly over the last month than 100% of stocks on the market. In the Medical Devices industry, which ranks 117 out of 146 industries, the stock ranks higher than 100% of stocks. Vivos Therapeutics Inc has risen 970.50% over the past month, closing at $3.62 on November 2. During this period of time, the stock fell as low as $2.74 and as high as $4.99.

Overall Score - 67
VVOS has an Overall Score of 67. Find out what this means to you and get the rest of the rankings on VVOS!
Vivos Therapeutics Inc has a Long-Term Technical rank of 100. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 0% of the market scoring higher. In the Medical Devices industry which is number 115 by this metric, VVOS ranks better than 115% of stocks.

Important Dates for Investors in VVOS:

-Vivos Therapeutics Inc is set to release earnings on 2024-02-12. Over the last 12 months, the company has reported EPS of $-3.04. -We do not have a set dividend date for Vivos Therapeutics Inc at this time. Click Here To Get The Full Report on Vivos Therapeutics Inc (VVOS)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App